Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Valentina Farenza"'
Autor:
Nicoletta Staropoli, Francesca Scionti, Valentina Farenza, Federica Falcone, Francesco Luciano, Maria Renne, Maria Teresa Di Martino, Domenico Ciliberto, Ludovica Tedesco, Antonella Crispino, Caterina Labanca, Maria Cucè, Stefania Esposito, Giuseppe Agapito, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri, Mariamena Arbitrio
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 174, Iss , Pp 116478- (2024)
Background: Long-term survival induced by anticancer treatments discloses emerging frailty among breast cancer (BC) survivors. Trastuzumab-induced cardiotoxicity (TIC) is reported in at least 5% of HER2+BC patients. However, TIC mechanism remains unc
Externí odkaz:
https://doaj.org/article/525912e00ae24511943ab9978d60570d
Autor:
Nicoletta Staropoli, Angela Salvino, Federica Falcone, Valentina Farenza, Martina Costa, Giacomo Rossini, Francesco Manti, Antonella Crispino, Caterina Riillo, Domenico Ciliberto, Mariamena Arbitrio, Pierfrancesco Tassone, Pierosandro Tagliaferri
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe optimal strategy for the treatment of recurrent and/or advanced endometrial cancer is still undefined. Recently, despite the lack of any predictive biomarker, the combination of pembrolizumab with lenvatinib has improved survival outcom
Externí odkaz:
https://doaj.org/article/ff6871284696474fbf16f570be46d30f
Autor:
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua, Onofrio Cuomo, Katia Grillone, Caterina Riillo, Giulio Caridà, Francesca Scionti, Caterina Labanca, Caterina Romeo, Maria Anna Siciliano, Maria D'Apolito, Cristina Napoli, Martina Montesano, Valentina Farenza, Valentina Uppolo, Michele Tafuni, Federica Falcone, Giuseppe D'Aquino, Natale Daniele Calandruccio, Francesco Luciano, Licia Pensabene, Pierosandro Tagliaferri, Pierfrancesco Tassone
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 27, Iss , Pp 1191-1224 (2022)
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-re
Externí odkaz:
https://doaj.org/article/3c736b7269e24e3894170eed8e9340d9